Ferronova has developed a surgical oncology tracer system that aims to improve the treatment guidance and staging of complex cancers and help increase survival rates. Ferronova, the australian company developing a technology to help speed up the early detection of the spread of cancer received $3.5 million in funding as it plans human trials. Australian biotech company ferronova announced today it has secured a further a$11 million to progress the company’s nanoparticle platform to assist surgeons to more accurately locate.
Australian biotechnology company ferronova pty ltd today announced it had been awarded an $826,000 grant from the australian government’s biomedtech horizons (btmh).
